Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-PD: Sertraline + Olanzapine for Psychotic Depression
NCT00056472Phase 3Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jan 2003
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sertraline in psychotic depression, sponsored by Weill Cornell Medicine. Started Jan 2003; status: completed.
02
Drugs
sertraline
03
Conditions
psychotic depression
Beyond the preview
Go deeper on NCT00056472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056472.